Vascular Therapies

Vascular Therapies, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Cresskill, New Jersey, developing Sirogen, a proprietary sirolimus formulation delivered from a bioabsorbable collagen implant placed perivascularly at the time of surgery. The product is aimed at reducing surgical stenosis and improving arteriovenous fistula maturation and patency in end-stage renal disease patients who need hemodialysis vascular access. Sirolimus for dialysis vascular access carries FDA Fast Track status and Orphan Drug designation in both the United States and the European Union. The company ran the Phase 3 ACCESS trial (243 ESRD patients across 20 US sites) and the multinational Phase 3 ACCESS 2 trial, whose topline results presented in April 2025 did not meet the primary clinical fistula maturation endpoint. Vascular Therapies is a therapeutics developer, not a software company: it ships a drug-device combination product through clinical trials and regulatory review, and publishes no API, SDK, developer portal or machine-readable contract of any kind.

Vascular Therapies is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Medical Devices, and Drug Delivery.

1.8/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0
0 APIs
CompanyBiotechnologyPharmaceuticalsMedical DevicesDrug DeliveryClinical TrialsNephrologyHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/vascular-therapies: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Source (apis.yml)

apis.yml Raw ↑
aid: vascular-therapies
name: Vascular Therapies
description: 'Vascular Therapies, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Cresskill,
  New Jersey, developing Sirogen, a proprietary sirolimus formulation delivered from a bioabsorbable collagen implant placed
  perivascularly at the time of surgery. The product is aimed at reducing surgical stenosis and improving arteriovenous fistula
  maturation and patency in end-stage renal disease patients who need hemodialysis vascular access. Sirolimus for dialysis
  vascular access carries FDA Fast Track status and Orphan Drug designation in both the United States and the European Union.
  The company ran the Phase 3 ACCESS trial (243 ESRD patients across 20 US sites) and the multinational Phase 3 ACCESS 2 trial,
  whose topline results presented in April 2025 did not meet the primary clinical fistula maturation endpoint. Vascular Therapies
  is a therapeutics developer, not a software company: it ships a drug-device combination product through clinical trials
  and regulatory review, and publishes no API, SDK, developer portal or machine-readable contract of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/vascular-therapies/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
x-company-domain: vasculartx.com
x-company-domain-status: Offline as of 2026-09-02. www.vasculartx.com returns Webflow's unpublished-domain "404 - Page not
  found" catch-all for the site root and for every indexed path (/about, /news, /robots.txt); the apex vasculartx.com is CNAMEd
  to proxy-ssl.webflow.com and returns nginx 403 Forbidden for every path. Not wired as a Website pointer because a confirmed
  dead page is a false claim, not a web presence.
x-harvest-source-listing: 'https://forgeglobal.com/vascular-therapies_stock/ — the secondary-market listing this company was
  harvested from. Deliberately NOT wired as type Website: a trading-venue listing page is not the company''s own web presence,
  and crediting it as one is the roadmap#56 false-credit defect.'
specificationVersion: '0.20'
created: '2026-09-02'
modified: '2026-09-02'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Drug Delivery
- Clinical Trials
- Nephrology
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common: []
x-enrichment:
  date: '2026-09-02'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Vascular Therapies is a clinical-stage biopharma developing Sirogen, a sirolimus-eluting collagen implant for hemodialysis
    vascular access — there is no software product to expose an API for, and its own web presence is additionally offline,
    with www.vasculartx.com returning Webflow's unpublished-domain 404 catch-all on the site root and on every indexed path.
  evidence:
  - url: https://www.vasculartx.com/
    status: 404
  - url: https://www.vasculartx.com/news
    status: 404
  - url: https://vasculartx.com/
    status: 403
  - url: https://vasculartx.com/openapi.json
    status: 403
  - url: https://vasculartx.com/.well-known/agent-card.json
    status: 403
  - url: https://api.vasculartx.com/
    status: 0
  - url: https://developer.vasculartx.com/
    status: 0
  - url: https://github.com/vasculartx
    status: 404
  checked: '2026-09-02'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/vascular-therapies"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/vascular-therapies/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/vascular-therapies/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.